Insufficient scRNA-seq data for expression of CYP19A1 at single-cell level.
Insufficient scRNA-seq data for expression of CYP19A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 85% | 339.01 | 558 / 653 | 4% | 0.09 | 24 / 605 |
skin | 70% | 865.65 | 1268 / 1809 | 13% | 1.19 | 59 / 472 |
adipose | 80% | 697.27 | 965 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 61% | 351.97 | 158 / 258 | 14% | 3.63 | 33 / 230 |
ovary | 67% | 328.11 | 120 / 180 | 2% | 0.04 | 8 / 430 |
bladder | 57% | 189.81 | 12 / 21 | 6% | 0.34 | 32 / 504 |
breast | 56% | 256.97 | 259 / 459 | 3% | 1.77 | 39 / 1118 |
blood vessel | 57% | 202.02 | 758 / 1335 | 0% | 0 | 0 / 0 |
spleen | 54% | 73.34 | 129 / 241 | 0% | 0 | 0 / 0 |
lung | 38% | 76.94 | 219 / 578 | 4% | 0.09 | 50 / 1155 |
heart | 39% | 61.69 | 336 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 36% | 221.45 | 330 / 929 | 0% | 0 | 0 / 0 |
brain | 9% | 16.00 | 226 / 2642 | 24% | 0.63 | 170 / 705 |
esophagus | 19% | 31.81 | 281 / 1445 | 8% | 0.14 | 15 / 183 |
pancreas | 17% | 23.50 | 56 / 328 | 7% | 0.16 | 13 / 178 |
prostate | 23% | 64.76 | 56 / 245 | 0% | 0 | 0 / 502 |
intestine | 10% | 11.58 | 100 / 966 | 3% | 0.07 | 18 / 527 |
stomach | 9% | 13.64 | 32 / 359 | 5% | 0.13 | 13 / 286 |
muscle | 13% | 31.48 | 106 / 803 | 0% | 0 | 0 / 0 |
uterus | 8% | 9.48 | 14 / 170 | 3% | 0.16 | 16 / 459 |
eye | 0% | 0 | 0 / 0 | 9% | 0.74 | 7 / 80 |
liver | 0% | 0 | 0 / 226 | 9% | 0.81 | 35 / 406 |
kidney | 3% | 2.71 | 3 / 89 | 1% | 0.12 | 9 / 901 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006703 | Biological process | estrogen biosynthetic process |
GO_2000866 | Biological process | positive regulation of estradiol secretion |
GO_0030879 | Biological process | mammary gland development |
GO_0032355 | Biological process | response to estradiol |
GO_0006949 | Biological process | syncytium formation |
GO_0030540 | Biological process | female genitalia development |
GO_0002677 | Biological process | negative regulation of chronic inflammatory response |
GO_0060736 | Biological process | prostate gland growth |
GO_0061370 | Biological process | testosterone biosynthetic process |
GO_0016125 | Biological process | sterol metabolic process |
GO_0006694 | Biological process | steroid biosynthetic process |
GO_0060065 | Biological process | uterus development |
GO_0010760 | Biological process | negative regulation of macrophage chemotaxis |
GO_0006710 | Biological process | androgen catabolic process |
GO_0008585 | Biological process | female gonad development |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0070330 | Molecular function | aromatase activity |
GO_0009055 | Molecular function | electron transfer activity |
GO_0016712 | Molecular function | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
GO_0019825 | Molecular function | oxygen binding |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
GO_0008395 | Molecular function | steroid hydroxylase activity |
Gene name | CYP19A1 |
Protein name | Aromatase (CYPXIX) (Cytochrome P450 19A1) Cytochrome P450 family 19 subfamily A member 1 Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase) |
Synonyms | ARO1 CYAR CYP19 |
Description | FUNCTION: A cytochrome P450 monooxygenase that catalyzes the conversion of C19 androgens, androst-4-ene-3,17-dione (androstenedione) and testosterone to the C18 estrogens, estrone and estradiol, respectively . Catalyzes three successive oxidations of C19 androgens: two conventional oxidations at C19 yielding 19-hydroxy and 19-oxo/19-aldehyde derivatives, followed by a third oxidative aromatization step that involves C1-beta hydrogen abstraction combined with cleavage of the C10-C19 bond to yield a phenolic A ring and formic acid . Alternatively, the third oxidative reaction yields a 19-norsteroid and formic acid. Converts dihydrotestosterone to delta1,10-dehydro 19-nordihydrotestosterone and may play a role in homeostasis of this potent androgen . Also displays 2-hydroxylase activity toward estrone . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) . . |
Accessions | Q8IYG4 P11511 ENST00000559646.1 Q45RG7 ENST00000396402.6 [P11511-1] ENST00000559653.1 H0YLS2 ENST00000557858.5 [P11511-2] Q05CU4 H0YKN1 Q7Z471 H0YLP1 ENST00000558328.5 ENST00000439712.6 ENST00000559878.5 [P11511-1] ENST00000405913.7 [P11511-2] H0YK57 ENST00000396404.8 [P11511-1] ENST00000453807.6 ENST00000559980.5 ENST00000561075.5 E7EQ08 ENST00000405011.6 E9PGZ6 ENST00000557934.5 H0YNJ7 E7EPL6 |